Life Science TN releases state policy agenda for 2021
Life Science Tennessee (LST), the member-based advocacy organization for the industry sector in the Volunteer State, has announced its policy agenda for 2021.
At the state level, the association is asking elected and appointed policymakers to:
- Continue to support the industry that is bringing new cures to market, including the development and adoption of opioid alternatives.
- Pass legislation that would make permanent the provisions of the State’s Executive Order regulating laboratory personnel by permanently eliminating the burdensome restrictions and leveling the playing field for industry labs vs. state-operated labs so that industry can access a larger pool of qualified candidates.
- Restore funding for the Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Matching Fund to bolster entrepreneurship to exciting, job-creating Tennessee companies.
- Continue to support the mission of the TennCare Rare Disease Advisory Council, established last session, which advises the TennCare Drug Utilization Review Board on products and medications for treatment of rare disease.
- Offer continued support for a simplified and streamlined approach to medical device oversight through LST’s compromise with the Tennessee Board of Pharmacy.
Due to COVID-19 restrictions on access to the Cordell Hull Building and the State Capitol, LST will not be hosting its annual “Day on the Hill” in February.
